Probióticos y aparato digestivo. Evidencias actuales

Guarner, 2003, Gut flora in health and disease, Lancet, 361, 512, 10.1016/S0140-6736(03)12489-0 Ley, 2006, Ecological and evolutionary forces shaping microbial diversity in the human intestine, Cell, 124, 837, 10.1016/j.cell.2006.02.017 Egert, 2006, Beyond diversity: functional microbiomics of the human colon, Trends Microbiol, 14, 86, 10.1016/j.tim.2005.12.007 Tannock, 2001, Molecular assessment of intestinal microflora, Am J Clin Nutr, 73, 410S, 10.1093/ajcn/73.2.410s Bouskra, 2008, Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis, Nature, 456, 507, 10.1038/nature07450 Yamanaka, 2003, Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches, J Immunol, 170, 816, 10.4049/jimmunol.170.2.816 Eckburg, 2005, Diversity of the human intestinal microbial flora, Science, 308, 1635, 10.1126/science.1110591 Marshall, 1999, Prediction of resource utilization and case cost for acute nonvariceal upper gastrointestinal hemorrhage at a canadian community hospital, Am J Gastroenterol, 94, 1841, 10.1111/j.1572-0241.1999.01215.x Verdú, 2006, Specific probiotic therapy attenuates antibiotic-induced visceral hypersensitivity in mice, Gut, 55, 182, 10.1136/gut.2005.066100 Chaudhary, 1962, The irritable colon syndrome: a study of the clinical features, predisposing causes and prognosis in 130 cases, Q J Med, 31, 307 Mearin, 2007, Síndrome del intestino irritable y enfermedad inflamatoria intestinal: ¿el eslabón perdido en el espectro de la inflamación? Longstreth, 2006, Functional bowel disorders, Gastroenterology, 130, 1480, 10.1053/j.gastro.2005.11.061 Thompson, 2000, Irritable bowel syndrome in general practice: prevalence, characteristics, and referral, Gut, 46, 78, 10.1136/gut.46.1.78 Camilleri, 2002, Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome, Aliment Pharmacol Ther, 16, 1407, 10.1046/j.1365-2036.2002.01305.x Mearin, 2001, Irritable bowel yndrome prevalence varies enormousy depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in the general population, Scand J Gastroenterol, 36, 1155, 10.1080/00365520152584770 Hungin, 2003, The prevalence, patterns and impact of irritable bowel síndrome: an international survey on 40 000 subjects, Aliment Pharmacol Ther, 17, 643, 10.1046/j.1365-2036.2003.01456.x Camilleri, 2000, Economic burden of irritable bowel syndrome. Proposed strategies to control expeditures, Pharmacoeconomics, 17, 331, 10.2165/00019053-200017040-00003 Badia, 2002, Burden of illness in irritable bowel syndrome (IBS) comparing Rome I and Rome II criteria, Pharmacoeconomics, 20, 749, 10.2165/00019053-200220110-00004 Spiller, 2003, Postinfectious irritable bowel syndrome, Gastroenterology, 124, 1662, 10.1016/S0016-5085(03)00324-X Mearin, 2005, Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study, Gastroenterology, 129, 98, 10.1053/j.gastro.2005.04.012 Chadwick, 2002, Activation of the mucosal immune system in irritable bowel syndrome, Gastroenterology, 122, 1778, 10.1053/gast.2002.33579 Tornblom, 2002, Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome, Gastroenterology, 123, 1972, 10.1053/gast.2002.37059 Barbara, 2004, Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome, Gastroenterology, 126, 693, 10.1053/j.gastro.2003.11.055 O’Mahony, 2005, Lactobacillus and bifidobacterium in irritable bowel syndrome: symptoms and relationship to cytokine profiles, Gastroenterology, 128, 541, 10.1053/j.gastro.2004.11.050 Malinen, 2005, Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR, Am J Gastroenterol, 100, 373, 10.1111/j.1572-0241.2005.40312.x Gade, 1989, Paraghurt for patients with irritable bowel syndrome. A controlled clinical investigation from general practice, Scand J Prim Health Care, 7, 23, 10.3109/02813438909103666 Nobaek, 2000, Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome, Am J Gastroenterol, 95, 1231, 10.1111/j.1572-0241.2000.02015.x Niedzielin, 2001, A controlled, doubleblind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome, Eur J Gastroenterol Hepatol, 13, 1143, 10.1097/00042737-200110000-00004